ORIGINAL ARTICLESVasodilator‐stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events
Under an Elsevier user license
open archive
Keywords
biological resistance to clopidogrel
coronary angioplasty
major adverse cardiovascular events
platelet reactivity
vasodilator‐stimulated phosphoprotein phosphorylation
Cited by (0)
Copyright © 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.